National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$29.95
add to cart

Rights & Permissions

topleft topright

The Children's Vaccine Initiative: Achieving the Vision (1993)
Institute of Medicine (IOM)

Citation Manager

. "Appendix H: Historical Record of Vaccine Product License Holders in the United States." The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press, 1993.

Please select a format:

BibTeX EndNote RefMan


Page
203
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Children's Vaccine Initiative: Achieving the Vision

Company and Vaccine or Product

Date of License

Date of Revocation

Tetanus toxoid

09/22/1959

02/06/1979

Tetanus & diphtheria toxoids adsorbed (for adult use)

07/27/1970

02/06/1979

Typhoid

07/11/1950

02/06/1979

University of Illinoisa

 

 

BCG vaccine

07/07/1950

05/29/1987

Wellcomed

 

 

Rubella virus, live

03/01/1977

 

Wyeth Laboratories

 

 

Adenovirus, live, oral, type 4

07/01/1980

 

Adenovirus, live, oral, type 7

07/01/1980

 

Cholera

07/16/1952

 

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

09/11/1970

 

Diphtheria toxoid

05/19/1944

05/19/1987

DT, adsorbed

09/11/1970

 

Influenza

12/13/1961

 

Pertussis vaccine

07/16/1952

05/19/1987

Rabies vaccine

08/11/1982

08/07/1986

Smallpox

05/19/1944

 

Tetanus toxoid

05/19/1944

 

Tetanus toxoid, adsorbed

09/11/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

09/11/1970

 

Typhoid

07/16/1952

 

a Company no longer produces any vaccines.

b Connaught Laboratories, Inc., (U.S.) and Connaught Laboratories, Ltd (Canada), are subsidiaries of Pasteur-Mérieux Sérums et Vaccins (France).

c Evans-Medical is a division of Medeva International, plc (United Kingdom); Medeva International plc acquired the vaccine business from Wellcome in 1991.

d Lederle Laboratories acquired Praxis Biologics in 1989. Lederle-Praxis Biologicals is now a business unit of American Cyanamid.

e Company produces one vaccine only for U.S. market.

f Sclavo spa is now owned by Ciba-Geigy (Switzerland) and Chiron (U.S.).

SOURCE: Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland.

Page
203